LQDA•benzinga•
Liquidia Scores FDA Nod For Lung Disease Drug Yutrepia, Faces Legal Challenge
Summary
Liquidia gains FDA approval for Yutrepia to treat PAH and PH-ILD, with funding in place despite ongoing patent litigation with United Therapeutics
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 27, 2025 by benzinga